Acute Kidney Injury Following Paediatric Cardiac Surgery
p-MiVAKI
A Feasibility Study to Consider the Role of Microvesicles (MV) and MV Derived microRNA (miRNA) in Acute Kidney Injury (AKI) Following Paediatric Cardiac Surgery: p-MiVAKI Study
2 other identifiers
observational
24
1 country
1
Brief Summary
Acute kidney injury (AKI) complicates over 50% of cardiac surgical procedures in children where it increases morbidity and the use of healthcare resources. The pathogenesis of AKI is poorly understood, current diagnostic tests lack specificity and sensitivity, and there is no effective treatment. Improving outcomes in patients at risk of AKI has recently been defined as a National Health Service priority. The investigators are currently undertaking a program of work that is evaluating the role of plasma-derived microvesicles (MV) and MV associated microRNAs (miRNA) as diagnostic biomarkers or therapeutic targets in cardiac surgery patients at risk of developing AKI. Preliminary results indicate that these biomarkers may have clinical utility in adults. An important consideration is whether these biomarkers also have utility in children undergoing cardiac surgery. Measurement of MV at serial time points in children presents ethical challenges related to conducting clinical research in critically ill subjects. It also presents technical challenges related to the very small volumes of blood that may be sampled safely from babies and infants undergoing surgery. The aim of the study is to provide estimates of the perioperative variance of MV concentrations in 24 children undergoing cardiac surgery, as well as the frequency of AKI and other adverse events, protocol adherence and recruitment rates. This will assist with the design of a subsequent prospective observational study that will consider the role of MV/miRNA in children undergoing cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2014
CompletedStudy Start
First participant enrolled
October 1, 2014
CompletedFirst Posted
Study publicly available on registry
November 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedJanuary 30, 2020
May 1, 2017
2.6 years
September 2, 2014
January 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change from baseline in annexin V positive microvesicles
Mean plasma concentration of Annexin V positive MV and the concentration variance in plasma from arterial blood samples collected prior to anaesthetic induction, and at 6-12 and 24 hours postoperatively.
Pre-operatively, 6-12 hrs post-op and 24 hrs post-op
change from baseline in microvesicles derived miRNA
Mean plasma concentration of MV derived miRNA and the concentration variance in plasma from arterial blood samples collected prior to anaesthetic induction, and at 6-12 and 24 hours postoperatively.
Pre-operatively, 6-12 hrs post-op and 24 hrs post-op
Secondary Outcomes (10)
Eligibility
pre-operatively
Recruitment
preoperatively
Protocol non-adherence
Pre-operatively, 6-12 hrs post-op and 24 hrs post-op
Acute Kidney Injury
preoperatively, postoperatively every day until day 7
Variation in Renal inflammation
Pre-operatively, 6-12 hrs post-op and 24 hrs post-op
- +5 more secondary outcomes
Study Arms (1)
Children undergoing cardiac surgery
Paediatric patients (\<17 years with a body weight \>2000g) undergoing cardiac surgery for congenital heart disease with extracorporeal circulation
Interventions
cardiac surgery with extracorporeal circulation for congenital heart disease
Eligibility Criteria
Children undergoing cardiac surgery in a tertiary academic cardiac surgery unit
You may qualify if:
- Patients undergoing congenital heart operations with cardio-pulmonary bypass.
- Patients aged ≤ 17 years of age.
- Patients with a body weight \> 2kg.
You may not qualify if:
- Patients with pre-existing inflammatory state: sepsis undergoing treatment, acute kidney injury within 5 days or chronic inflammatory disease.
- Emergency (operation before the beginning of the next working day after decision to operate) or salvage procedure (patients requiring cardiopulmonary resuscitation - external cardiac massage - en route to the operating theatre or prior to induction of anaesthesia. This does not include cardiopulmonary resuscitation following induction of anaesthesia)
- Patients where Extracorporeal Membrane Oxygenation (ECMO) support is required.
- Patients likely to require ECMO postoperatively.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leicesterlead
- University Hospitals, Leicestercollaborator
- Heart Link Children's Charitycollaborator
- British Heart Foundationcollaborator
Study Sites (1)
Glenfield Hospital
Leicester, Leicestershire, LE3 9QP, United Kingdom
Related Publications (1)
Sullo N, Mariani S, JnTala M, Kumar T, Wozniak MJ, Smallwood D, Pais P, Westrope C, Lotto A, Murphy GJ. An Observational Cohort Feasibility Study to Identify Microvesicle and Micro-RNA Biomarkers of Acute Kidney Injury Following Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2018 Sep;19(9):816-830. doi: 10.1097/PCC.0000000000001604.
PMID: 29912813DERIVED
Biospecimen
* serum * EDTA plasma * citrated blood * hirudin blood * urine
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gavin J Murphy, Prof
University of Leicester
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2014
First Posted
November 13, 2014
Study Start
October 1, 2014
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
January 30, 2020
Record last verified: 2017-05